Zevra sets $10M AZSTARYS milestone for 2023; merger with Acer announced

ZEVRA THERAPEUTICS, INC.

Next AZSTARYS sales milestone is $10.0M; expected to be achieved in FY 2023 per current prescription trends.
Zevra announced merger with Acer Therapeutics; Acer will become a wholly owned subsidiary upon shareholder approval.
Zevra hosted a conference call on Aug 31, 2023 to provide supplemental information on the merger.
Employee communication from interim CEO Christal Mickle distributed to Acer staff on Aug 31, 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.